Skip to content

Command Ultra II

by Cardiac Pacemakers, Inc. 2 variants

510(k) K831216

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK831216 Date12 Jul 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Command Ultra II is an Implantable Pacemaker Pulse-Generator, designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when necessary. This device is intended for patients with bradycardia or other cardiac conduction disorders requiring chronic pacing support.

This device is supplied as a single-use implantable component and is regulated under FDA 510(k) clearance (K831216) as a Class III medical device. It is intended for surgical implantation by qualified healthcare professionals in a sterile operating environment, with no noted MRI safety restrictions. The product code DXY classifies it under the regulatory category for implantable pacemaker pulse-generators.

Other devices from Cardiac Pacemakers, Inc.

See all devices from Cardiac Pacemakers, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is the Command Ultra II designed to support, and how does it work?

    The Command Ultra II is designed for patients with bradycardia or other cardiac conduction disorders that require chronic pacing support. It functions as an implantable pacemaker pulse-generator, delivering regulated electrical impulses to the heart muscle to maintain a proper heart rhythm when the natural conduction system fails.

  • Is the Command Ultra II intended for reuse, or is it a single-use device?

    The Command Ultra II is explicitly supplied as a single-use implantable component. It is intended for one-time surgical implantation by qualified healthcare professionals and is not designed for reuse.

  • What regulatory pathway does the Command Ultra II follow, and what does that mean for its use?

    The Command Ultra II is regulated under the FDA’s 510(k) clearance process (K831216) as a Class III medical device, meaning it has undergone a thorough review to demonstrate substantial equivalence to a predicate device. This clearance confirms it meets FDA safety and effectiveness standards for use as an implantable pacemaker pulse-generator in a sterile operating environment.

  • Are there any special considerations for storage or handling of the Command Ultra II before implantation?

    While the provided data does not specify storage conditions, the Command Ultra II is an implantable device intended for surgical use in a sterile environment. It should be handled according to standard sterile medical device protocols to ensure patient safety and device integrity prior to implantation.